Based on the Extendicare Inc stock forecast from 0 analysts, the average analyst target price for Extendicare Inc is not available over the next 12 months. Extendicare Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Extendicare Inc is Slightly Bullish , which is based on 10 positive signals and 5 negative signals. At the last closing, Extendicare Inc’s stock price was USD 7.49. Extendicare Inc’s stock price has changed by +2.11% over the past week, +12.39% over the past month and +46.76% over the last year.
No recent analyst target price found for Extendicare Inc
No recent average analyst rating found for Extendicare Inc
Company Overview Extendicare Inc
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada. Read Less
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as...Read More
Frequently Asked Questions About Extendicare Inc (EXETF) Stock
Stock Target Advisor's fundamental analysis for Extendicare Inc's stock is Slightly Bullish .
EXETF stock's dividend yield is 4.67%.
Our analysis grades EXETF stock's dividend yield at C. This means that EXETF stock's dividend yield is above 75% of the stocks in the Medical Care Facilities sector in the OTC exchange.
Based on this EXETF may be a average dividend stock for its sector.
Unfortunately we do not have enough data on EXETF's stock to indicate what its average analyst target is.
EXETF stock's Price/Earning ratio is 14.23.
Our analysis grades EXETF stock's Price / Earning ratio at F. This means that EXETF stock's Price/Earning ratio is above 42.00000000000001% of the stocks in the Medical Care Facilities sector in the OTC exchange.
Based on this EXETF may be fairly valued for its sector
The last closing price of EXETF's stock was USD 7.49.
The most recent market capitalization for EXETF is USD 0.62B.
Unfortunately we do not have enough analyst data on EXETF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Extendicare Inc's stock.
As per our most recent records Extendicare Inc has 0 Employees.
Extendicare Inc's registered address is 3000 Steeles Avenue East, Markham, ON, Canada, L3R 4T9.
You can get more information about it from Extendicare Inc's website at https://www.extendicare.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Extendicare Inc (EXETF) Stock
Stock Target Advisor's fundamental analysis for Extendicare Inc's stock is Slightly Bullish .
EXETF stock's dividend yield is 4.67%.
Our analysis grades EXETF stock's dividend yield at C. This means that EXETF stock's dividend yield is above 75% of the stocks in the Medical Care Facilities sector in the OTC exchange.
Based on this EXETF may be a average dividend stock for its sector.
Unfortunately we do not have enough data on EXETF's stock to indicate what its average analyst target is.
EXETF stock's Price/Earning ratio is 14.23.
Our analysis grades EXETF stock's Price / Earning ratio at F. This means that EXETF stock's Price/Earning ratio is above 42.00000000000001% of the stocks in the Medical Care Facilities sector in the OTC exchange.
Based on this EXETF may be fairly valued for its sector
The last closing price of EXETF's stock was USD 7.49.
The most recent market capitalization for EXETF is USD 0.62B.
Unfortunately we do not have enough analyst data on EXETF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Extendicare Inc's stock.
As per our most recent records Extendicare Inc has 0 Employees.
Extendicare Inc's registered address is 3000 Steeles Avenue East, Markham, ON, Canada, L3R 4T9.
You can get more information about it from Extendicare Inc's website at https://www.extendicare.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for EXETF !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
